Vimab Group AB (publ) (OM:VIMAB) signed letter of intent to acquire Solomon Oy for â¬2.3 million on June 20, 2023. Initial purchase price of â¬1.8 million includes â¬0.5 million in cash, â¬1.3 million in Vimab shares. Signing of share transfer agreement is planned for Q3 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.25 SEK | -0.60% |
|
-4.07% | -6.88% |
May. 08 | Vimab Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Vimab Group AB (OM:VIMAB) agreed to acquire Tranfoten Aktiebolag. | CI |
1st Jan change | Capi. | |
---|---|---|
-6.88% | 17.58M | |
+8.23% | 7.56B | |
-26.82% | 3.38B | |
-3.45% | 2.43B | |
+12.70% | 1.71B | |
-24.42% | 900M | |
-4.94% | 652M | |
-11.08% | 655M | |
-6.15% | 590M | |
-17.76% | 543M |
- Stock Market
- Equities
- VIMAB Stock
- News Vimab Group AB
- Vimab Group AB (OM: VIMAB) signed letter of intent to acquire Solomon Oy for €2.3 million.